French biotech firm LNC Therapeutics is to change its name to YSOPIA Bioscience in a move designed to reflect a change in research direction towards drugs that harness the gut microbiome’s potential.
French biotech firm LNC Therapeutics is to enter into a licence agreement with the University of Valencia for a patent outlining the Christensenella gut bacteria's role in addressing mood disorders.